Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2019

01.04.2019 | Clinical Study

Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adults

verfasst von: Andrea C. Lo, Normand Laperriere, David Hodgson, Eric Bouffet, James Nicholson, Michael McKenzie, Juliette Hukin, Sylvia Cheng, Karen J. Goddard

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The study objectives were to describe patterns of practice for intracranial germ cell tumors (IGCT) in adolescents and young adults (AYA) and to determine factors associated with practice patterns.

Methods

A survey was written containing questions on the management of two 17-year old males, one with localized pineal germinoma and the other with localized pineal non-germinomatous germ cell tumor (NGGCT). An invitation to participate anonymously in the survey was e-mailed to 119 oncologists who treat brain tumors across Canada.

Results

Seventy-two (61%) of the 119 oncologists participated in the study. For the germinoma case, the most common treatment approaches were whole ventricular radiotherapy (WVRT) and chemotherapy (CH) (56%), WVRT alone (15%), and craniospinal radiotherapy (CSRT) alone (10%); for physicians recommending WVRT + CH, most frequently selected whole ventricular doses were 24 Gy (57%) and 18 Gy (20%). Chemotherapy was included in the treatment of germinoma by 96% of pediatric physicians vs. 54% of adult physicians (P = 0.001). The most common treatment approaches for NGGCT were CSRT + CH (44%), WVRT + CH (21%), and pineal gland RT + CH (15%). The selection of craniospinal vs. smaller-volume RT was not associated with the physicians’ specialty, percentage of practice treating brain tumors, number of IGCTs seen, or size of institution.

Conclusions

There is wide variation in the management of IGCT in AYA across Canada. A 17-year old male with a localized pineal germinoma is highly likely to receive chemotherapy if managed by a pediatric oncologist, while the same patient is much less likely to receive chemotherapy if managed by an adult oncologist.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro-Oncology 14(9):1194–1200CrossRefPubMedPubMedCentral McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro-Oncology 14(9):1194–1200CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Kim DI, Yoon PH, Ryu YH, Jeon P, Hwang GJ (1998) MRI of germinomas arising from the basal ganglia and thalamus. Neuroradiology 40(8):507–511CrossRefPubMed Kim DI, Yoon PH, Ryu YH, Jeon P, Hwang GJ (1998) MRI of germinomas arising from the basal ganglia and thalamus. Neuroradiology 40(8):507–511CrossRefPubMed
3.
Zurück zum Zitat Tamaki N, Lin T, Shirataki K, Hosoda K, Kuruta H, Matsumoto S, Ito H (1990) Germ cell tumors of the thalamus and the basal ganglia. Childs Nerv Syst 6(1):3–7CrossRefPubMed Tamaki N, Lin T, Shirataki K, Hosoda K, Kuruta H, Matsumoto S, Ito H (1990) Germ cell tumors of the thalamus and the basal ganglia. Childs Nerv Syst 6(1):3–7CrossRefPubMed
5.
Zurück zum Zitat Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL (2004) Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr Blood Cancer 43(2):126–133CrossRefPubMed Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL (2004) Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr Blood Cancer 43(2):126–133CrossRefPubMed
6.
Zurück zum Zitat Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL (1996) Chemotherapy without irradiation–a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 14(11):2908–2915CrossRefPubMed Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL (1996) Chemotherapy without irradiation–a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 14(11):2908–2915CrossRefPubMed
7.
Zurück zum Zitat da Silva NS, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J, Kellie S, Parker R, Garvin J, Finlay J (2010) Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study. Pediatr Blood Cancer 54(3):377–383CrossRefPubMed da Silva NS, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J, Kellie S, Parker R, Garvin J, Finlay J (2010) Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study. Pediatr Blood Cancer 54(3):377–383CrossRefPubMed
8.
Zurück zum Zitat Thomas DM, Albritton KH, Ferrari A (2010) Adolescent and young adult oncology: an emerging field. J Clin Oncol 28(32):4781–4782CrossRefPubMed Thomas DM, Albritton KH, Ferrari A (2010) Adolescent and young adult oncology: an emerging field. J Clin Oncol 28(32):4781–4782CrossRefPubMed
9.
Zurück zum Zitat Bleyer A, Budd T, Montello M (2006) Adolescents and young adults with cancer. Cancer 107(7):1645–1655CrossRefPubMed Bleyer A, Budd T, Montello M (2006) Adolescents and young adults with cancer. Cancer 107(7):1645–1655CrossRefPubMed
10.
Zurück zum Zitat Bleyer WA (2001) Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 38(1):1–10CrossRef Bleyer WA (2001) Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 38(1):1–10CrossRef
11.
Zurück zum Zitat Tai E, Buchanan N, Eliman D, Westervelt L, Beaupin L, Lawvere S, Bleyer A (2014) Understanding and addressing the lack of clinical trial enrollment among adolescents with cancer. Pediatrics 133(Supplement):S98–S103CrossRefPubMedPubMedCentral Tai E, Buchanan N, Eliman D, Westervelt L, Beaupin L, Lawvere S, Bleyer A (2014) Understanding and addressing the lack of clinical trial enrollment among adolescents with cancer. Pediatrics 133(Supplement):S98–S103CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Albritton KH, Coccia P (2014) Influencing referral of adolescents and young adults with cancer to sites with higher rates of trial enrollment. Pediatrics 133(Supplement):S104–S108CrossRefPubMed Albritton KH, Coccia P (2014) Influencing referral of adolescents and young adults with cancer to sites with higher rates of trial enrollment. Pediatrics 133(Supplement):S104–S108CrossRefPubMed
13.
Zurück zum Zitat Roth ME, O’Mara AM, Seibel NL, Dickens DS, Langevin A-M, Pollock BH, Freyer DR (2016) Low enrollment of adolescents and young adults onto cancer trials: insights from the community clinical oncology program. JOP 12(4):e388–e395CrossRefPubMed Roth ME, O’Mara AM, Seibel NL, Dickens DS, Langevin A-M, Pollock BH, Freyer DR (2016) Low enrollment of adolescents and young adults onto cancer trials: insights from the community clinical oncology program. JOP 12(4):e388–e395CrossRefPubMed
14.
Zurück zum Zitat Al-Naeeb AB, Murray M, Horan G, Harris F, Kortmann RD, Nicholson J, Ajithkumar T (2018) Current management of intracranial germ cell tumours. Clin Oncol 30(4):204–214CrossRef Al-Naeeb AB, Murray M, Horan G, Harris F, Kortmann RD, Nicholson J, Ajithkumar T (2018) Current management of intracranial germ cell tumours. Clin Oncol 30(4):204–214CrossRef
15.
Zurück zum Zitat Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC (2015) Consensus on the management of intracranial germ-cell tumours. Lancet Oncol 16(9):e470–e477CrossRefPubMed Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC (2015) Consensus on the management of intracranial germ-cell tumours. Lancet Oncol 16(9):e470–e477CrossRefPubMed
16.
Zurück zum Zitat Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, Patte C, Ricardi U, Saran F, Frappaz D (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-Oncology 15(6):788–796CrossRefPubMedPubMedCentral Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, Patte C, Ricardi U, Saran F, Frappaz D (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-Oncology 15(6):788–796CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Khatua S, Fangusaro J, Dhall G, Boyett J, Wu S, Bartels U, The Childrens’s Oncology Group (COG) (2016) Current treatment approach for children with newly diagnosed central nervous system (CNS) localized germinoma (ACNS1123 Stratum 2). Neuro-Oncology 18(3):iii45–iii46PubMedCentral Khatua S, Fangusaro J, Dhall G, Boyett J, Wu S, Bartels U, The Childrens’s Oncology Group (COG) (2016) Current treatment approach for children with newly diagnosed central nervous system (CNS) localized germinoma (ACNS1123 Stratum 2). Neuro-Oncology 18(3):iii45–iii46PubMedCentral
18.
Zurück zum Zitat Kanamori M, Kumabe T, Saito R, Yamashita Y, Sonoda Y, Ariga H, Takai Y, Tominaga T (2009) Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis. J Neurosurg 4(6):506–514 Kanamori M, Kumabe T, Saito R, Yamashita Y, Sonoda Y, Ariga H, Takai Y, Tominaga T (2009) Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis. J Neurosurg 4(6):506–514
19.
Zurück zum Zitat Fuller BG, Kapp DS, Cox R (1994) Radiation therapy of pineal region tumors: 25 new cases and a review of 208 previously reported cases. Radiat Oncol Biol 28(1):229–245CrossRef Fuller BG, Kapp DS, Cox R (1994) Radiation therapy of pineal region tumors: 25 new cases and a review of 208 previously reported cases. Radiat Oncol Biol 28(1):229–245CrossRef
20.
Zurück zum Zitat Calaminus G, Frappaz D, Kortmann RD, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre ML, Ricardi U, Mann JR, Göbel U, Alapetite C, Murray MJ, Nicholson JC (2017) Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial. Neuro-Oncology 19(12):1661–1672CrossRefPubMedPubMedCentral Calaminus G, Frappaz D, Kortmann RD, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre ML, Ricardi U, Mann JR, Göbel U, Alapetite C, Murray MJ, Nicholson JC (2017) Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial. Neuro-Oncology 19(12):1661–1672CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Fangusaro J, Wu S, Macdonald S, Murphy E, Shaw D, Bartels U, Khatua S, Boyett J, Williams-Hughes C, Souweidane M, Lu H-M, Morris D, Panigrahy A, Onar-Thomas A, Fouladi M, Gajjar A, Dhall G (2018) A phase 2 trial of response-based radiation therapy for patients with localized central nervous system germ cell tumors (CNS GCT): a Children’s Oncology Group (COG) Study. Neuro-Oncology 20(2):i86CrossRefPubMedCentral Fangusaro J, Wu S, Macdonald S, Murphy E, Shaw D, Bartels U, Khatua S, Boyett J, Williams-Hughes C, Souweidane M, Lu H-M, Morris D, Panigrahy A, Onar-Thomas A, Fouladi M, Gajjar A, Dhall G (2018) A phase 2 trial of response-based radiation therapy for patients with localized central nervous system germ cell tumors (CNS GCT): a Children’s Oncology Group (COG) Study. Neuro-Oncology 20(2):i86CrossRefPubMedCentral
22.
Zurück zum Zitat Mokhtech M, Rotondo RL, Bradley JA, Sandler ES, Nanda R, Logie N, Aldana PR, Morris CG, Indelicato DJ (2018) Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Pediatr Blood Cancer 65(6):e26997CrossRefPubMed Mokhtech M, Rotondo RL, Bradley JA, Sandler ES, Nanda R, Logie N, Aldana PR, Morris CG, Indelicato DJ (2018) Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Pediatr Blood Cancer 65(6):e26997CrossRefPubMed
23.
Zurück zum Zitat Breen WG, Blanchard MJ, Rao AN, Daniels DJ, Buckner JC, Laack NNI (2017) Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy. Pediatr Blood Cancer 64(11):e26637–e26639CrossRef Breen WG, Blanchard MJ, Rao AN, Daniels DJ, Buckner JC, Laack NNI (2017) Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy. Pediatr Blood Cancer 64(11):e26637–e26639CrossRef
24.
Zurück zum Zitat Goldman S, Bouffet E, Fisher G (2010) A phase II trial of neoadjuvant chemotherapy ± second-look surgery prior to radiotherapy for non-germinomatous germ cell tumors (NGGCT): Children’s Oncology Group ACNS0122 Goldman S, Bouffet E, Fisher G (2010) A phase II trial of neoadjuvant chemotherapy ± second-look surgery prior to radiotherapy for non-germinomatous germ cell tumors (NGGCT): Children’s Oncology Group ACNS0122
25.
Zurück zum Zitat Bromberg JEC, Baumert BG, de Vos F, Gijtenbeek JMM, Kurt E, Westermann AM, Wesseling P (2013) Primary intracranial germ-cell tumors in adults: a practical review. J Neurooncol 113(2):175–183CrossRefPubMed Bromberg JEC, Baumert BG, de Vos F, Gijtenbeek JMM, Kurt E, Westermann AM, Wesseling P (2013) Primary intracranial germ-cell tumors in adults: a practical review. J Neurooncol 113(2):175–183CrossRefPubMed
26.
Zurück zum Zitat Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, Patte C, Ricardi U, Saran F, Frappaz D (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-Oncology 15(6):788–796CrossRefPubMedPubMedCentral Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, Patte C, Ricardi U, Saran F, Frappaz D (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-Oncology 15(6):788–796CrossRefPubMedPubMedCentral
Metadaten
Titel
Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adults
verfasst von
Andrea C. Lo
Normand Laperriere
David Hodgson
Eric Bouffet
James Nicholson
Michael McKenzie
Juliette Hukin
Sylvia Cheng
Karen J. Goddard
Publikationsdatum
01.04.2019
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2019
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-019-03159-2

Weitere Artikel der Ausgabe 2/2019

Journal of Neuro-Oncology 2/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.